Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study
International Journal of Immunopathology and Pharmacology · 2024
DOI: 10.1177/03946320241265263 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2024. Verfasst von Rasha Ahmed Ghorab und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, X-ray Repair Cross Complementing Protein 1, Liver Neoplasms, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is the most common and fatal primary liver cancer. Genetic variants of DNA repair systems can reduce DNA repair capability and increase HCC risk.
Objectives
This study aimed to examine, in Egyptian hepatitis C virus (HCV) patients, the relationship between the X-ray repair cross-complementing group 1 (XRCC1) rs1799782 single nucleotide polymorphism (SNP) and HCC susceptibility.
Methods
We included 100 adult HCV-positive patients with HCC and 100 adult HCV-positive patients with liver cirrhosis as pathological controls. XRCC1 rs1799782 SNP genotyping was done in both groups using quantitative real-time PCR (qPCR). The distribution of genotypes in patients and controls was compared using several inheritance models.
Results
We found that the CT genotype, when analyzed under both the co-dominant (OR (95 % CI): 2.147 (1.184-3.893), p = .012) and the over-dominant (OR (95 % CI): 2.055 (1.153-3.660), p = .015) models, as well as the combined CT and TT genotypes under the dominant model (OR (95 % CI) of 1.991 (1.133-3.497), p = .017), were associated with increased susceptibility to HCC. The frequency of the T allele was higher among HCC participants (32%) compared to those with cirrhosis (23.5%) and carrying the T allele increased the risk of HCC by 1.532 times, however, these associations did not reach statistical significance ( p-values >0.05). Moreover, the variant T allele was associated with worse clinical manifestations and laboratory results among the HCC group, but AFP levels were not affected significantly.
Conclusions
Egyptians with XRCC1 rs1799782 SNP may have a higher risk of HCV-related HCC. More extensive multi-center prospective investigations must confirm this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
- Department of Internal Medicine /Allergy and Clinical Immunology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
- Department of Medical Microbiology and Immunology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
ORCID-Profile: Shaimaa H Fouad, Sara I Taha
Zitieren
APA
Ghorab, R. A., Fouad, S. H., Elsaadawy, Y., Hamdy, M., & Taha, S. I. (2024). Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320241265263
Vancouver
Ghorab RA, Fouad SH, Elsaadawy Y, Hamdy M, Taha SI. Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study. International Journal of Immunopathology and Pharmacology. 2024. doi:10.1177/03946320241265263
BibTeX
@article{Ghorab2024,
author = {Ghorab, Rasha Ahmed and Fouad, Shaimaa H and Elsaadawy, Yara and Hamdy, Marwa and Taha, Sara I},
title = {Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2024},
doi = {10.1177/03946320241265263}
}
EUVIMED